江苏神华药业

Jiangsu Shenhua Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale production of fungal-based medicinal products. Established as a leader in the deep-layer fungal fermentation industry, the company focuses on therapeutic areas such as oncology, nephrology, and hepatology. Its flagship products include Lentinan for injection and various Cordyceps-derived formulations used to treat chronic diseases and boost immune function. The company operates advanced GMP-certified manufacturing facilities capable of producing both active pharmaceutical ingredients and finished dosage forms. As a key subsidiary of Nanjing Pharmaceutical, it leverages a robust distribution network to serve both domestic and international markets.